These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 4854063)

  • 1. Regional cutaneous metastases in melanoma of the limb.
    Cox KR
    Surg Gynecol Obstet; 1974 Sep; 139(3):385-6. PubMed ID: 4854063
    [No Abstract]   [Full Text] [Related]  

  • 2. [Preventive lymph node excision in the treatment concept of melanoma of the extremities].
    Binder J; Henneking K
    Zentralbl Chir; 1996; 121(6):474-7. PubMed ID: 8767334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sentinel node biopsy in cutaneous malignant melanoma of the lower extremities].
    Kjaer BK; Knudsen MA; Dahlstrøm KK
    Ugeskr Laeger; 1999 Apr; 161(16):2358-61. PubMed ID: 10235040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of regional lymph node excision for prognosis of advanced malignant melanoma treated by perfusion of the extremity].
    Huber R; Krüger I; Stützer H
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():118-21. PubMed ID: 9101808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Indications for regional lymphadenectomy in melanoblastoma of the skin of the extremities].
    Vagner RI; Khachaturian LM
    Vopr Onkol; 1974; 20(9):33-8. PubMed ID: 4428655
    [No Abstract]   [Full Text] [Related]  

  • 6. Pathology of the lymph nodes in patients with malignant melanoma.
    Cochran AJ; Robert ME; Wen DR
    Pathology (Phila); 1994; 2(2):385-400. PubMed ID: 9420909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathobiology of the sentinel node.
    Cochran AJ; Ohsie SJ; Binder SW
    Curr Opin Oncol; 2008 Mar; 20(2):190-5. PubMed ID: 18300769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of prophylactic regional node dissection in the treatment of Stage I melanoma: a review.
    Hiner BC; Minton JP
    Ohio State Med J; 1983 Sep; 79(9):716-8. PubMed ID: 6634021
    [No Abstract]   [Full Text] [Related]  

  • 9. Regional lymph node dissections in malignant melanoma.
    Lawton GP; Ariyan S
    Clin Plast Surg; 2000 Jul; 27(3):431-40, ix. PubMed ID: 10941563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel lymphadenectomy for cutaneous melanoma: who, what, and why.
    Bower M; Scoggins CR
    J Ky Med Assoc; 2009 Jul; 107(7):253-8. PubMed ID: 19678500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Indications for preventive axillary lymphadenectomy in melanoma of the skin of the upper extremity].
    Vagner RI; Anisimov VV
    Vestn Khir Im I I Grek; 1987 May; 138(5):46-50. PubMed ID: 3672737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymph node ratio in melanoma: A marker of variation in surgical quality?
    Spillane AJ; Winstanley J; Thompson JF
    Cancer; 2009 Jun; 115(11):2384-7. PubMed ID: 19306419
    [No Abstract]   [Full Text] [Related]  

  • 13. [Ilio-inguinal lymphadenectomy in the treatment of regional metastases of cutaneous melanoblastomas of the lower extremities].
    Vagner RI; Stoliarov VI; Khachaturian LM
    Vestn Khir Im I I Grek; 1971 Aug; 107(8):55-61. PubMed ID: 5159447
    [No Abstract]   [Full Text] [Related]  

  • 14. Sentinel lymph node biopsy for melanoma--standard of care?
    Otley CC
    Dermatol Surg; 2000 Nov; 26(11):1067-9. PubMed ID: 11096398
    [No Abstract]   [Full Text] [Related]  

  • 15. Cutaneous melanoma--retrospective study of a small series of patients.
    Metcalf JS; Hawk JC; Kreutner A
    J S C Med Assoc; 1981 Mar; 77(3):113-7. PubMed ID: 6938740
    [No Abstract]   [Full Text] [Related]  

  • 16. Sentinel lymph node micrometastasis may predict non-sentinel involvement in cutaneous melanoma patients.
    Glumac N; Hocevar M; Zadnik V; Snoj M
    J Surg Oncol; 2008 Jul; 98(1):46-8. PubMed ID: 18452214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sentinel lymph node dissection in patients with malignant melanoma. Diagnostic and therapeutic standards].
    Arens A; Osinga J; Schwipper V; Schober O; Tilkorn H; Liebau J
    Chirurg; 2003 Jul; 74(7):665-70. PubMed ID: 12883795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Extent of lymph node clearance required in stage III-B melanoma].
    Avril MF
    Ann Dermatol Venereol; 2008 Feb; 135(2):91-2. PubMed ID: 18342087
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of malignant melanoma.
    Kroon BB; Nieweg OE
    Ann Chir Gynaecol; 2000; 89(3):242-50. PubMed ID: 11079795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chances of a patient with melanoma developing in transit disease are doubled by undergoing sentinel lymph node biopsy (SLNB).
    Russell-Jones R; Powell AM; Acland K; Calonje E; O'Doherty M; Healy C
    Eur J Surg Oncol; 2005 Mar; 31(2):210-1. PubMed ID: 15698741
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.